Abstract
The new, extremely potent and enantioselective D-2 agonist LY 163502 failed to induce compulsive stereotyped behaviour. Very low doses (3–6 μg/kg) inhibited spontaneous sniffing and locomotion, while higher doses (12–50 μg/kg) induced episodes of non-stereotyped sniffing and chewing; these actions showed complete enantioselectivity. Up to 200-fold higher doses modestly induced only locomotion. Responsivity to LY 163502 was enantioselectively blocked by the selective D-2 antagonist R-piquindone. This responsivity was also enantioselectively blocked by the selective D-1 antagonist R-SK&F 83566 but, additionally, episodes of atypical limb/body jerking behaviour were released; thus, LY 163502 induced such jerking only when tonic D-1 activity was suppressed. These data extend our notion that there may be at least two forms of functional interaction between D-1 and D-2 receptor systems: one cooperative, as in the regulation of typical sniffing, and another oppositional, as in the regulation of atypical jerking.
Similar content being viewed by others
References
Arnt J, Hyttel J, Perregaard J (1987) Dopamine D-1 receptor agonists combined with the selective D-2 agonist quinpirole facilitate the expression of oral stereotyped behaviour in rats. Eur J Pharmacol 133:137–145
Azzaro AJ, Liccione J, Lucci J (1987) Opposing actions of D-1 and D-2 dopamine receptor-mediated alterations of adenosine-3′, 5′-cyclic monophosphate (cyclic AMP) formation during amphetamine-induced release of endogenous dopamine in vitro. Naunyn-Schmiedeberg's Arch Pharmacol 336:133–138
Barlow RB (1983) Biodata handling with microcomputers. Elsevier, Amsterdam
Braun AR, Chase TN (1986) Obligatory D-1/D-2 receptor interaction in the generation of dopamine agonist related behaviours. Eur J Pharmacol 131:301–306
Breese GR, Creese I (1986) Neurobiology of central D-1 dopamine receptors. Plenum Press, New York
Bymaster FP, Reid LR, Nichols CL, Kornfeld EC, Wong DT (1986) Elevation of acetylcholine levels in striatum of rat brain by LY 163502, trans (-)-5,5a,6,7,8,9,9a,10-octahydro-6-propylpyrimido-4,5-g-quinolin-2-amine hydrochloride, a potent and stereoselective dopamine (D-2) agonist. Life Sci 38:317–322
Carlson JH, Bergstrom DA, Walters JR (1986) Neurophysiological evidence that D-1 dopamine receptor blockade attenuates postsynaptic but not autoreceptor-mediated effects of dopamine agonists. Eur J Pharmacol 123:237–251
Carlson JH, Bergstrom DA, Walters JR (1987) Stimulation of both D-1 and D-2 dopamine receptors appears necessary for full expression of postsynaptic effects of dopamine agonists: a neurophysiological study. Brain Res 400:205–218
Clark D, White FJ (1987) D-1 dopamine receptor — the search for a function: a critical evaluation of the D-1/D-2 dopamine receptor classification and its functional implications. Synapse 1:347–388
Costall B, Naylor RJ, Pycock C (1976) Non-specific supersensitivity of striatal dopamine receptors after 6-hydroxydopamine lesion of the nigrostriatal pathway. Eur J Pharmacol 35:275–283
Cross AJ, Hewitt L, Slater P, Waddington JL (1987) Interaction of benzazepine enantiomers related to SCH 23390 with rat brain serotonin receptors. Br J Pharmacol [Suppl] 90:244 P
Davidson AB, Boff E, MacNeil DA, Wanger J, Cook L (1983) Pharmacological effects of Ro22-1319: a new antipsychotic agent. Psychopharmacology 79:32–39
Fletcher GH, Starr MS (1987) Topography of dopamine behaviours mediated by D-1 and D-2 receptors revealed by intrastriatal injection of SKF 38393, lisuride and apomorphine in rats with a unilateral 6-hydroxydopamine-induced lesion. Neuroscience 20:589–597
Foreman MM, Hall JL (1987) Effects of D-2 dopaminergic receptor stimulation on male rat sexual behaviour. J Neural Transm 68:153–170
Grabowska-Anden M, Anden NE (1983) Stimulation of postsynaptic DA-2 receptors produces jerks in reserpine-treated rats. J Pharm Pharmacol 35:543–545
Hyttel J (1983) SCH 23390: the first selective dopamine D-1 antagonist. Eur J Pharmacol 91:153–154
Iorio LC, Barnett A, Leitz FH, Houser VP, Korduba CA (1983) SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems. J Pharmacol Exp Ther 226:462–468
Kebabian JW, Calne DB (1979) Multiple receptors for dopamine. Nature 277:93–96
Kelly E, Nahorski SR (1987) Dopamine D-2 receptors inhibit D-1-stimulated cyclic AMP accumulation in striatum but not limbic forebrain. Naunyn-Schmiedeberg's Arch Pharmacol 335:508–512
Mashurano M, Waddington JL (1986) Stereotyped behaviour in response to the selective D-2 dopamine receptor agonist RU 24213 is enhanced by pretreatment with the selective D-1 agonist SK&F 38393. Neuropharmacology 25:947–949
Molloy AG, Waddington JL (1984) Dopaminergic behaviour stereospecifically promoted by the D-1 agonist R-SK&F 38393 and selectively blocked by the D-1 antagonist SCH 23390. Psychopharmacology 82:409–410
Molloy AG, Waddington JL (1987a) Assessment of grooming and other behavioural responses to the D-1 dopamine receptor agonist SK&F 38393 and its R- and S-enantiomers in the intact adult rat. Psychopharmacology 92:164–168
Molloy AG, Waddington JL (1987b) Pharmacological characterisation in the rat of grooming and other behavioural responses to the D-1 dopamine receptor agonist R-SK&F 38393. J Psychopharmacol 1:177–183
Molloy AG, O'Boyle KM, Pugh MT, Waddington JL (1986) Locomotor behaviours in response to new selective D-1 and D-2 dopamine receptor agonists, and the influence of selective antagonists. Pharmacol Biochem Behav 25:249–253
Murray AM, Waddington JL (1989) The induction of grooming and vacuous chewing by a series of selective D-1 dopamine receptor agonists: two directions of D-1:D-2 interaction. Eur J Pharmacol (in press)
O'Boyle KM, Waddington JL (1984) Identification of the enantiomers of SK&F 83566 as specific and stereoselective antagonists at the striatal D-1 dopamine receptor: comparisons with the D-2 enantioselectivity of Ro22-1319. Eur J Pharmacol 106:219–220
O'Boyle KM, Waddington JL (1988) Agonist and antagonist properties of 1-phenyl-3-benzazepine analogues at the D-1 dopamine receptor. Br J Pharmacol [Suppl] 82:132 P
Seeman P (1980) Brain dopamine receptors. Pharmacol Rev 32:229–313
Starr BS, Starr MS (1986) Differential effects of dopamine D-1 and D-2 agonists and antagonists on velocity of movement, rearing and grooming in the mouse. Neuropharmacology 25:455–463
Stoof JC, Kebabian JW (1981) Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum. Nature 294:366–368
Stoof JC, Verheijden PFHM, Leysen JE (1987) Stimulation of D-2 receptors in rat nucleus accumbens slices inhibits dopamine and acetylcholine release but not cyclic AMP formation. Brain Res 423:364–368
Strombom U (1977) Antagonism by haloperidol of locomotor depression induced by small doses of apomorphine. J Neural Transm 40:191–194
Waddington JL (1986a) Behavioural correlates of the action of selective D-1 dopamine receptor antagonists: impact of SCH 23390 and SKF 83566, and functionally interactive D-1:D-2 receptor systems. Biochem Pharmacol 35:3661–3667
Waddington JL (1986b) Bromocriptine, selective D-2 dopamine receptor agonists and D-1 dopaminergic tone. TIPS 7:223–224
Waddington JL (1988) Therapeutic potential of selective D-1 dopamine receptor agonists and antagonists in psychiatry and neurology. Gen Pharmacol 19:55–60
Waddington JL, O'Boyle KM (1987) The D-1 dopamine receptor and the search for its functional role: from neurochemistry to behaviour. Rev Neurosci 1:157–184
Waddington JL, O'Boyle KM (1989) Drugs acting on brain dopamine receptors: a conceptual re-evaluation five years after the first selective D-1 antagonist. Pharmacol Ther (in press)
Waddington JL, Molloy AG, O'Boyle KM, Mashurano M (1986) Motor consequences of D-1 dopamine receptor stimulation and blockade. Clin Neuropharmacol [Suppl 4] 9:20–22
Walters JR, Bergstrom DA, Carlson JH (1986) Effects of D-1 and D-2 receptor stimulation on single unit activity in the substantia nigra and globus pallidus. In: Woodruff GN, Poat J, Roberts PJ (eds) Dopaminergic system and their regulation. MacMillan, London, pp 63–78
White FJ (1987) D-1 dopamine receptor stimulation enables the inhibition of nucleus accumbens neurons by a D-2 receptor agonist. Eur J Pharmacol 135:101–105
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Murray, A.M., Waddington, J.L. Further evidence for two directions of D-1:D-2 dopamine receptor interaction revealed concurrently in distinct elements of typical and atypical behaviour: studies with the new enantioselective D-2 agonist LY 163502. Psychopharmacology 98, 245–250 (1989). https://doi.org/10.1007/BF00444699
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00444699